Альфа-пвп: описание и особенности

The chemical name alpha-pyrrolidinovalerophenone is synonymous with Alpha-PVP. It was placed under a temporary nationwide ban in the United States effective February 2014.

The onset of effects can be subtle or delayed, which may lead to accidental overdosing due to re-dosing. Media reports claiming Alpha-PVP causes 'superhuman strength' or specific bizarre behaviors in all users are often sensationalized and not universally supported by clinical data.

It acts as a psychostimulant with properties similar to cocaine and MDMA. It is a molecular analogue of pyrovalerone and structurally related to MDPV (methylenedioxypyrovalerone).

Structural modifications, such as expanding the pyrrolidine ring to piperidine, significantly reduce potency at dopamine transporters.

The European Union banned Alpha-PVP in 2015. Animal studies indicate that Alpha-PVP induces hyperlocomotion and aberrant or stereotypic behaviors.

Common street names for Alpha-PVP include 'flakka', 'gravel', and 'niff'. In animal studies, Alpha-PVP has been found to be equally potent and effective as MDPV in terms of reinforcing effects and locomotor stimulation.

Alpha-PVP (alpha-pyrrolidinovalerophenone) is a synthetic cathinone stimulant. Routes of administration include smoking, snorting (intranasal), injection, and oral ingestion.

The drug was illegal in only a handful of US states prior to the temporary nationwide ban in 2014.

It is specifically illegal in New South Wales, Australia, following fatal incidents involving users. Alpha-PVP is classified as a synthetic cathinone, part of the 'bath salts' family of designer drugs.

Intranasal administration leads to effects appearing within minutes, lasting approximately 3 hours. User reports indicate a transition from initial euphoria to distress and anxiety is common.

Acute effects in humans include euphoria, increased sociability, heightened libido, energy, and time distortion. Its mechanism involves inhibiting the reuptake of dopamine (DAT) and norepinephrine (NET), leading to increased synaptic concentrations.

Severe adverse effects include paranoia, agitation, hallucinations, delirium, and loss of motor control.

Visual appearance often includes small white or bluish translucent crystals with a shiny surface. Selective blockade of catecholamine transporters may increase addiction risk compared to non-selective substances.

Forensic analysis often uses LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry) to detect Alpha-PVP in biological samples. Alpha-PVP and its metabolites can be detected in blood and urine postmortem.

In New Zealand, it is not explicitly scheduled but treated as a Class C substance due to structural similarity to controlled drugs. Alpha-PVP is more potent than methamphetamine in some rat self-administration studies when compared to MDPV, but less potent than methamphetamine in substitution tests.

Research suggests Alpha-PVP may impair spatial learning and memory through brain mitochondrial dysfunction in animal models.